Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1999
12/07/1999US5998168 Expression of gene products from genetically manipulated strains of bordetella
12/07/1999US5998167 Expression control polynucleotides derived from spliceosomal protein gene promoters
12/07/1999US5998166 Human cd16-ii variants, dna sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses.
12/07/1999US5998165 Polynucleotides encoding a protein associated with pancreatic cancer
12/07/1999US5998164 Polynucleotides encoding human G-protein coupled receptor GPRZ
12/07/1999US5998157 Contacting sample with antibody and binding partner in presence of acylated protein aggregate
12/07/1999US5998155 Stable composition of immobilized protein having affinity for biotin
12/07/1999US5998154 Somatostatin receptor peptide antigens and antibodies
12/07/1999US5998144 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/07/1999US5998136 Selection systems and methods for identifying genes and gene products involved in cell proliferation
12/07/1999US5998134 Retinoblastoma gene-cancer suppressor and regulator
12/07/1999US5998130 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997882 Epitopic regions of pneumococcal surface protein A
12/07/1999US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses
12/07/1999US5997873 Method of preparation of heat shock protein 70-peptide complexes
12/07/1999US5997872 Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof
12/07/1999US5997871 Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
12/07/1999US5997870 Isolated peptides which bind to HLA-B44 Molecules
12/07/1999US5997869 Peptides containing a fusion joint of a chimeric protein encoded by DNA spanning a tumor-associated chromosomal translocation and their use as immunogens
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999US5997861 Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
12/07/1999US5997860 Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines
12/07/1999US5997859 Gene encoding a conditionally lethal gene product which activates a purine- or pyrimidine-based prodrug into an agent that is cytotoxic to said metastatic carcinoma; and administering said prodrug to said patient
12/07/1999US5997857 Co-administration of interleukin-3 mutants with colony stimulating factors
12/07/1999US5997844 Technetium-99m labeled peptides for imaging
12/07/1999US5997269 Means for discovering microbes
12/07/1999CA2119773C Macrophage activating factor from animal vitamin d-binding protein
12/07/1999CA2116764C Immunoreactive hepatitis c virus polypeptide compositions
12/07/1999CA2074943C Process for the enzymatic cleavage of recombinant proteins using iga proteases
12/07/1999CA2073288C Manipulation of gene copy number in bordetella
12/07/1999CA2020663C Substitution analogues of magainin peptides
12/07/1999CA2004991C Deletion analogues of magainin peptides
12/07/1999CA1340846E Expression of biologically active platelet derived growth factor analogs in eucaryotic cells
12/07/1999CA1340841C Cecropin-like polypeptides with activity against gram-positive and gram-negative bacteria
12/07/1999CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
12/07/1999CA1340838C Coccidiosis vacine
12/07/1999CA1340837C Expression and secretion of heterologous proteins by yarrowia lipolytica transformants
12/02/1999WO1999062315A2 Method for altering the activity of proteins of the pka signaling pathway
12/02/1999WO1999061918A1 Method and means for caries prevention and susceptibility detection
12/02/1999WO1999061909A2 Methods and compositions for the detection of human herpesvirus
12/02/1999WO1999061656A2 Agent and method for modulation of cell migration
12/02/1999WO1999061653A2 Light-mediated regional analysis of biologic material
12/02/1999WO1999061652A1 Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes
12/02/1999WO1999061650A1 Cell culture process for producing glycoproteins
12/02/1999WO1999061649A1 Method for recovering soluble protein
12/02/1999WO1999061642A1 Recombinant aav vectors for gene therapy of hemophilia a
12/02/1999WO1999061639A2 Retroviral delivery system
12/02/1999WO1999061637A1 Gene sequences of rubella virus associated with attenuation
12/02/1999WO1999061635A2 Cotton cells, plants, and seeds genetically engineered to express insecticidal and fungicidal chitin binding proteins (lectins)
12/02/1999WO1999061634A1 Method of producing thy a-strains of vibrio cholerae, such strains and their use
12/02/1999WO1999061630A2 Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
12/02/1999WO1999061622A1 Xenobiotic related induction of gene expression
12/02/1999WO1999061621A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999WO1999061620A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999WO1999061619A2 Cell cycle genes, proteins and uses thereof
12/02/1999WO1999061618A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999WO1999061617A1 Interleukins-21 and 22
12/02/1999WO1999061616A2 DNA CODING FOR A Mg?2+/H+ OR Zn2+/H+¿ EXCHANGER AND TRANSGENIC PLANTS EXPRESSING SAME
12/02/1999WO1999061615A1 Kunitz domain polypeptide and materials and methods for making it
12/02/1999WO1999061614A2 Human socs proteins
12/02/1999WO1999061613A2 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/02/1999WO1999061612A1 Tumor suppressor
12/02/1999WO1999061611A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
12/02/1999WO1999061610A2 TUMOUR SUPPRESSOR GENES OF THE p53 FAMILY
12/02/1999WO1999061609A1 Calmodulin related protein
12/02/1999WO1999061608A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
12/02/1999WO1999061606A1 MAMMALIAN gb2 GABAB RECEPTORS
12/02/1999WO1999061604A2 A vector for gene trap, and a method for gene trapping by using the vector
12/02/1999WO1999061601A2 Aav5 vector and uses thereof
12/02/1999WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999WO1999061595A2 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999WO1999061589A2 Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
12/02/1999WO1999061584A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
12/02/1999WO1999061582A2 Transgenic animals having modified hedgehog signal transduction and uses related thereto
12/02/1999WO1999061580A2 Modification of cereal grain hardness via expression of puroindoline proteins
12/02/1999WO1999061579A2 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE
12/02/1999WO1999061477A2 Monoclonal antibody and assay for detecting piiinp
12/02/1999WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999WO1999061475A1 Method for separating and/or isolating plasma proteins by annularchromatography
12/02/1999WO1999061474A1 Purified human activin and process for producing the same
12/02/1999WO1999061473A1 Method for purification of borrelia lipoprotein ospa
12/02/1999WO1999061472A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061470A1 Respiratory nitrate reductase alpha subunit
12/02/1999WO1999061469A2 Prostate growth-associated membrane proteins
12/02/1999WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein
12/02/1999WO1999061467A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999WO1999061464A1 Process of purifying angiogenesis inhibitors
12/02/1999WO1999061463A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999WO1999061459A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999WO1999061458A1 Antigens and their detection
12/02/1999WO1999061453A2 priA
12/02/1999WO1999061452A2 acpS
12/02/1999WO1999061072A2 Methods of inhibiting clot formation
12/02/1999WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999WO1999061054A1 Nicotine immunogen
12/02/1999WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999WO1999061047A1 Compound delivery using rapidly dissolving collagen film
12/02/1999WO1999061046A1 Parasite antigens
1 ... 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 ... 2916